Invention Grant
- Patent Title: Vectors for transgene expression
-
Application No.: US14523218Application Date: 2014-10-24
-
Publication No.: US09932597B2Publication Date: 2018-04-03
- Inventor: On Kan
- Applicant: Adaptimmune Limited
- Applicant Address: GB Abingdon, Oxford
- Assignee: ADAPTIMMUNE LIMITED
- Current Assignee: ADAPTIMMUNE LIMITED
- Current Assignee Address: GB Abingdon, Oxford
- Agency: Vedder Price P.C.
- Agent Thomas J. Kowalski; Deborah L. Lu
- Priority: GB1318804 20131024
- Main IPC: C12N15/67
- IPC: C12N15/67 ; C12N15/86

Abstract:
The present invention relates to a vector system involving replacement of a Woodchuck Hepatitis Virus Post-Transcriptional Regulatory Element (WPRE) sequence with an unrelated short spacer sequence for efficient expression of nucleotides of interest in a retroviral vector system and methods of delivering and expressing nucleotides of interest to target cells.
Public/Granted literature
- US20150118714A1 VECTORS FOR TRANSGENE EXPRESSION Public/Granted day:2015-04-30
Information query
IPC分类: